Search Results - "Simoneau, Anne R"

Refine Results
  1. 1

    Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy by Liu, Zhongbo, Li, Xuesen, Simoneau, Anne R., Jafari, Mahtab, Zi, Xiaolin

    Published in Molecular carcinogenesis (01-03-2012)
    “…The incidence of human urinary bladder cancer increases markedly with age, suggesting a mechanistic connection between aging and bladder carcinogenesis and a…”
    Get full text
    Journal Article
  2. 2

    Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice by XIAOLIN ZI, SIMONEAU, Anne R

    Published in Cancer research (Chicago, Ill.) (15-04-2005)
    “…Consumption of the traditional kava preparation was reported to correlate with low and uncustomary gender ratios (more cancer in women than men) of cancer…”
    Get full text
    Journal Article
  3. 3

    Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice by Liu, Zhongbo, Song, Liankun, Xie, Jun, Simoneau, Anne R, Uchio, Edward, Zi, Xiaolin

    Published in Pharmaceutics (24-02-2022)
    “…Non-muscle-invasive bladder cancer (NMIBC) has one of the highest recurrence rates among all solid cancers and the highest lifetime treatment cost per patient…”
    Get full text
    Journal Article
  4. 4

    Lycopene Enhances Docetaxel's Effect in Castration-Resistant Prostate Cancer Associated with Insulin-like Growth Factor I Receptor Levels by Tang, Yaxiong, Parmakhtiar, Basmina, Simoneau, Anne R, Xie, Jun, Fruehauf, John, Lilly, Michael, Zi, Xiaolin

    Published in Neoplasia (New York, N.Y.) (01-02-2011)
    “…Docetaxel is currently the most effective drug for the treatment of castration-resistant prostate cancer (CRPC), but it only extends life by an average of 2…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness by Zi, Xiaolin, Guo, Yi, Simoneau, Anne R, Hope, Christopher, Xie, Jun, Holcombe, Randall F, Hoang, Bang H

    Published in Cancer research (Chicago, Ill.) (01-11-2005)
    “…The ability of Frzb/secreted Frizzled-related protein 3 (sFRP3) to inhibit Wnt signaling and the localization of Frzb/sFRP3 on chromosome 2q to a region…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Flavokawain B, a kava chalcone, induces apoptosis via up‐regulation of death‐receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth by Tang, Yaxiong, Li, Xuesen, Liu, Zhongbo, Simoneau, Anne R., Xie, Jun, Zi, Xiaolin

    Published in International journal of cancer (15-10-2010)
    “…Limited success has been achieved in extending the survival of patients with metastatic and hormone‐refractory prostate cancer (HRPC). There is a strong need…”
    Get full text
    Journal Article
  9. 9

    Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53 by Tang, Yaxiong, Simoneau, Anne R, Xie, Jun, Shahandeh, Babbak, Zi, Xiaolin

    “…Flavokawain A is the predominant chalcone from kava extract. We have assessed the mechanisms of flavokawain A's action on cell cycle regulation. In a p53…”
    Get full text
    Journal Article
  10. 10
  11. 11

    KAVA Chalcone, Flavokawain A, Inhibits Urothelial Tumorigenesis in the UPII-SV40T Transgenic Mouse Model by ZHONGBO LIU, XIA XU, XUESEN LI, SHUMAN LIU, SIMONEAU, Anne R, FENG HE, WU, Xue-Ru, XIAOLIN ZI

    “…Flavokawain A (FKA) is the predominant chalcone identified from the kava plant. We have previously shown that FKA preferentially inhibits the growth of p53…”
    Get full text
    Journal Article
  12. 12

    Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine by Meyskens, Jr, Frank L, Simoneau, Anne R, Gerner, Eugene W

    Published in Recent results in cancer research (2014)
    “…In vitro and in vivo preclinical results suggest that inhibition of polyamine synthesis inhibits the progression of prostate cancer. These findings has led to…”
    Get more information
    Journal Article
  13. 13

    Three-Dimensional Sonography With Needle Tracking: Role in Diagnosis and Treatment of Prostate Cancer by Shen, Feimo, Shinohara, Katsuto, Kumar, Dinesh, Khemka, Animesh, Simoneau, Anne R, Werahera, Priya N, Li, Lu, Guo, Yujun, Narayanan, Ramkrishnan, Wei, Liyang, Barqawi, Al, Crawford, E. David, Davatzikos, Christos, Suri, Jasjit S

    Published in Journal of ultrasound in medicine (01-06-2008)
    “…Image-guided prostate biopsy has become routine in medical diagnosis. Although it improves biopsy outcome, it mostly operates in 2 dimensions, therefore…”
    Get full text
    Journal Article
  14. 14

    Continent lower urinary tract reconstruction in the cervical spinal cord injured population by Zommick, Jason N, Simoneau, Anne R, Skinner, Donald G, Ginsberg, David A

    Published in The Journal of urology (01-06-2003)
    “…Patients with cervical spinal cord injury and upper extremity dysfunction are treated primarily with indwelling or condom catheters. We present our experience…”
    Get more information
    Journal Article
  15. 15
  16. 16

    α-Difluoromethylornithine and Polyamine Levels in the Human Prostate: Results of a Phase IIa Trial by Simoneau, Anne R., Gerner, Eugene W., Phung, Mai, McLaren, Christine E., Meyskens, Frank L.

    “…Fig. 1 compares the absolute values of putrescine, spermidine, spermine, and the spermidine/spermine ratio before and after DFMO treatment. Pretherapy…”
    Get full text
    Journal Article
  17. 17

    Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations by SIMONEAU, A. R, SPRUCK, C. H, GONZALEZ-ZULUETA, M, GONZALGO, M. L, CHAN, M. F, TSAI, Y. C, DEAN, M, STEVEN, K, HORN, T, JONES, P. A

    Published in Cancer research (Chicago, Ill.) (01-11-1996)
    “…The most common genetic alteration identified to date in bladder cancer is loss of heterozygosity (LOH) of chromosome 9, suggesting the presence of possible…”
    Get full text
    Journal Article
  18. 18

    Abstract 618: Rhodiola rosea L . extract, SHR-5, and metformin exhibit potent activity against bladder carcinogenesis in the UPII-mutant Ha-ras transgenic model by Liu, Zhongbo, Li, Xuesen, Liu, Shuman, Xu, Xia, Tian, Xuejiao, Simoneau, Anne R., Zi, Xiaolin

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract The incidence of human urinary bladder cancer increases markedly with age, suggesting a mechanistic connection between aging and bladder…”
    Get full text
    Journal Article
  19. 19

    Abstract 5681: Flavokawain B down-regulates SKP2 through a proteasome-dependent and ubiquitin-independent pathway, and acts synergistically with Bortezomib on inhibition of Skp2 expression and prostate cancer cell growth by Li, Xuesen, Liu, Zhongbo, Simoneau, Anne R., Zi, Xiaolin

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract The E3 ubiquitin ligase SKP2 (S-phase kinase-associated protein 2), an oncogenic protein, was found to be overexpressed in 557 of 622 (89.2%) primary…”
    Get full text
    Journal Article
  20. 20

    Abstract 619: Flavokawain A inhibits urinary bladder carcinogenesis in the UPII-SV40T transgenic mouse bladder cancer model by Liu, Zhongbo, Li, Xuesen, liu, Shuman, Xu, Xia, Tian, Xuejiao, Simoneau, Anne R., Wu, Xue-Ru, Zi, Xiaolin

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract The UPII-SV40T transgenic model of the mouse bladder reproduces a precursor to recurrent and invasive Transitional Cell Carcinoma (TCC): carcinoma in…”
    Get full text
    Journal Article